Genetic factors and clinical significance of acanthosis nigricans in obese Japanese children and adolescents

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 2, 2006, Pages 170-175

  Miura, Naoko ^a   Ikezaki, Ayako ^a   Iwama, Saika ^a   Matsuoka, Hisafumi ^a   Ito, Keiko ^a   Sugihara, Shigetaka ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

adrenergic receptor gene; Childhood obesity; Children and adolescents; Genetic factors; Lifestyle related disease

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; GENOMIC DNA; GLYCINE; INSULIN; LEPTIN;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ALLELE; ARTICLE; BODY MASS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; HEREDITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DNA; DNA PRIMERS; FEMALE; GENE FREQUENCY; HUMANS; JAPAN; LEPTIN; MALE; OBESITY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RADIOIMMUNOASSAY; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 31944439001     PISSN: 08035253     EISSN: 15023869     Source Type: Journal    
DOI: 10.1080/08035250500294015     Document Type: Article

References (33)

1. American Diabetes Association. Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care 2000; 23:381-9.
2. Richards GE, Cavallo A, Meyer WJ, Prince MJ, Peters EJ, Stuart CA, et al. Obesity, acanthosis nigricans, insulin resistance and hyperandrogenemia: pediatric perspective and natural history. J Pediatr 1985;107:893-7.
3. Stuart CA, Gilkison CR, Smith MM, Bosma AM, Bruce K, Nagamani M. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Pediatr 1998;37:73-9.
4. Stoddart ML, Wang W, Blevins KS, Blackett PR, Lee ET. Association of acanthosis nigricans with hyperinsulinemia compared with other selected risk factors for type 2 diabetes in Cherokee Indians. Diabetes Care 2002;25:1009-14.
5. Hirschler V, Aranda C, Oneto A, Gonzalez C, Jadzinsky M. Is acanthosis nigricans a marker of insulin resistance in obese children? Diabetes Care 2002;25:2353.
6. Nguyen TT, Keil MF, Russell DL, Pathomvanich A, Uwaifo GI, Sebring NG, et al. Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children. J Pediatr 2001;138:474-80.
7. Ikezaki A, Miura N, Kikuoka N, Kim HS, Matsuoka H, Ito K, et al. Clinical characteristics of obese Japanese children with acanthosis nigricans. Clin Pediatr Endocrinol 2001;10:47-52.
8. Dulloo AG. A sympathetic defense against obesity. Science 2002;297:780-1.
9. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med 1995;333:343-7.
10. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Eng J Med 1995;333:348-51.
11. Clement K, Vaisse C, Manning BSJ, Basdevant A, Guy-Grand R, Ruiz J, et al. Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-4.
12. Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Shimokawa K, Silver K, et al. A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Comm 1995;215:555-60.
13. Yoshida T, Sakane N, Umekawa T, Sakai M, Takanashi T, Kondo M. Mutation of β3-adrenergic-receptor gene and response to treatment of obesity. Lancet 1995;346:1433-4.
14. Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, et al. Association of Trp64Arg mutation of the β3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 1996;39:349-52.
15. Arner P. The β3-adrenergic-receptor - a cause and cure of obesity. N Engl J Med 1995;333:382-3.
16. Pulkkinen A, Kareinen A, Saarinen L, Heikkinen S, Lehto S, Laakso M. The codon 64 polymorphism of the beta3-adrenergic-receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients. Metabolism 1999;48:853-6.
17. Nagase T, Aoki A, Yamamoto M, Yasuda H, Kado S, Nishikawa M, et al. Lack of association between the Trp64Arg mutation in the β3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab 1997;82:1284-7.
18. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997;100:3005-13.
19. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999;42:98-101.
20. Kawamura T, Egusa G, Fujikawa R, Okubo M. Gln27Glu variant of the β2-adrenergic receptor gene is not associated with obesity and diabetes in Japanese-Americans. Metabolism 2001;50:443-6.
21. Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Elkasabany A, Gustat J. et al, Influence of the β2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart study. Int J Obes 2002;26:928-37.
22. Endo K, Yanagi H, Hirano C, Hamaguchi H, Tsuchiya S, Tomura S. Association of Trp64Arg polymorphism of the beta3-adrenergic receptor gene and no association of Gln223Arg polymorphism of the leptin receptor gene in Japanese schoolchildren with obesity. Int J Obes Relat Metab Disord 2000;24:443-9.
23. Arashiro R, Katsuren K, Fukuyama G, Ohta T. Effect of Trp64Arg mutation of the β3-adrenergic receptor gene and C161T substitution of the peroxisome proliferators activated receptor g gene on obesity in Japanese children. Pediatr Int 2003;45:135-41.
24. Matsuoka H, Iwama S, Miura N, Ikezaki A, Sugihara S. Impact of polymorphism of β2- and β3-adorenergic receptor genes on longitudinal changes in obesity in early childhood. Acta Paediatr 2004;93:430.
25. Yamazaki K, Matsuoka H, Kawanobe S, Fujita Y, Murata M. Japanese standard body weights for height by age and sex in 1990. Acta Pediatr Japonica, 1994;98:96-102 (in Japanese).
26. Ikezaki A, Hosoda H, Ito K, Iwama S, Miura N, Matsuoka H, et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002;51:3408-11.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
28. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endcrinol Metab 2000;85:2402-10.
29. Matsuoka H, Iwama S, Miura N, Ikezaki A, Sugihara S. Impact of polymorphism of human β-adrenergic receptor gene on changes in height during growth hormone treatment. Endocr J 2002;49:21-8.
30. Asayama K, Dobashi K, Hayashibe H, Kodera K, Uchida U, Nakane T, et al. Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys. Int J Obes 2002;26:208-13.
31. Asayama K, Ozeki T, Sugihara S, Ito K, Okada T, Tamai H, et al. Criteria for medical intervention in obese children: A new definition of 'Obesity disease' in Japanese children. Pediatr Int 2003;45:642-6.
32. Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med 2000;32(Suppl 1):78-84.
33. Green SA, Turki J, Innis M, Liggett SB. Amino-terminal polymorphisms of the human β2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994;33:9413-9.